SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 149 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $19,980 | +109.7% | 20,812 | +63.8% | 0.00% | – |
| Q1 2023 | $9,530 | +106.9% | 12,706 | +1.6% | 0.00% | – |
| Q4 2022 | $4,607 | -23.2% | 12,503 | -3.3% | 0.00% | – |
| Q3 2022 | $6,000 | -40.0% | 12,934 | +1.7% | 0.00% | – |
| Q2 2022 | $10,000 | -37.5% | 12,715 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | 0.0% | 12,715 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -42.9% | 12,715 | 0.0% | 0.00% | – |
| Q3 2021 | $28,000 | -41.7% | 12,715 | 0.0% | 0.00% | – |
| Q2 2021 | $48,000 | +17.1% | 12,715 | 0.0% | 0.00% | – |
| Q1 2021 | $41,000 | -4.7% | 12,715 | 0.0% | 0.00% | – |
| Q4 2020 | $43,000 | -27.1% | 12,715 | -12.1% | 0.00% | – |
| Q3 2020 | $59,000 | +20.4% | 14,465 | 0.0% | 0.00% | – |
| Q2 2020 | $49,000 | +44.1% | 14,465 | 0.0% | 0.00% | – |
| Q1 2020 | $34,000 | -35.8% | 14,465 | 0.0% | 0.00% | – |
| Q4 2019 | $53,000 | -55.8% | 14,465 | 0.0% | 0.00% | – |
| Q3 2019 | $120,000 | – | 14,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |